SCHEMBL16626775

SCHEMBL16626775

CNCc1cn(S(=O)(=O)c2cccnc2)c2cc(Nc3ccc(Cl)cc3C)cnc12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 4/20 0.38
SLC6A4 P31645 4/20 0.38
NAMPT P43490 3/20 0.35
HTT P42858 2/20 0.35
BRD4 O60885 1/20 0.35
SLC6A3 Q01959 2/20 0.34
KCNH2 Q12809 1/20 0.34
LMNA P02545 1/20 0.34
HTR6 P50406 1/20 0.34
USP2 O75604 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
ALDH1A1 P00352 1/20 0.34
HPGD P15428 1/20 0.34
RAB9A P51151 1/20 0.34
PIK3CA P42336 1/20 0.33
TP53 P04637 1/20 0.33
MAPT P10636 1/20 0.33
THRB P10828 1/20 0.33
SLC40A1 Q9NP59 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL16619468 0.99 SLC6A2 (0.38) SLC6A2SLC6A4NAMPTHTTBRD4
SCHEMBL17971593 0.92 HTT (0.37) SLC6A2SLC6A4NAMPTHTTHTR6
Hydrochloric Acid SCHEMBL16618939 0.92 HTT (0.37) SLC6A2SLC6A4NAMPTHTTHTR6
SCHEMBL16626663 0.91 ALDH1A1 (0.40) SLC6A4NAMPTBRD4HTR6SMN1; SMN2
Hydrochloric Acid SCHEMBL16618976 0.90 ALDH1A1 (0.40) SLC6A4NAMPTBRD4HTR6SMN1; SMN2
SCHEMBL16626778 0.88 NAMPT (0.39) NAMPTBRD4LMNAHTR6SMN1; SMN2
SCHEMBL16626666 0.88 HTR6 (0.39) SLC6A2SLC6A4BRD4SLC6A3KCNH2
Hydrochloric Acid SCHEMBL16618946 0.88 NAMPT (0.39) NAMPTBRD4LMNAHTR6SMN1; SMN2
SCHEMBL17971521 0.87 HTR6 (0.40) SLC6A2SLC6A4NAMPTHTTSLC6A3
Hydrochloric Acid SCHEMBL16619579 0.87 HTR6 (0.38) SLC6A2SLC6A4BRD4SLC6A3KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3052484-B1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAE WOONG PHARMA (KR) 2018-03-21 EP claimed
EP-3052484-B1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAE WOONG PHARMA (KR) 2018-03-21 EP disclosed
US-9676714-B2 Sulfonylindole derivatives and method for preparing the same DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2017-06-13 US disclosed
US-9676714-B2 Sulfonylindole derivatives and method for preparing the same DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2017-06-13 US disclosed
US-20160221946-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2016-08-04 US disclosed
US-20160221946-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2016-08-04 US disclosed
WO-2015050412-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2015-04-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160221946-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME GIPR, PGC, SI SLC6A2 2731/4885SLC6A4 1266/4885NAMPT 1610/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.